Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing hospital-based safety monitoring study of Xueshuantong for injection (lyophilized)
ChiCTR-OPC-14005718Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Henan University of Chinese Medicine
- Start
- Mar 2015
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of panax notoginseng extract, sponsored by First Affiliated Hospital of Henan University of Chinese Medicine. Primary endpoints: Adverse drug reactions/adverse drug events, Severity of adverse drug reactions and 2 more. Planned start Mar 2015; status: not yet recruiting.
02
Drugs
panax notoginseng extract
Beyond the preview
Go deeper on ChiCTR-OPC-14005718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-14005718.